海南省西部地区60岁及以上老年人群2型糖尿病的患病率及其影响因素分析

吕金芳 李文霞 黎美兰 王永研 郭桂莲

吕金芳, 李文霞, 黎美兰, 王永研, 郭桂莲. 海南省西部地区60岁及以上老年人群2型糖尿病的患病率及其影响因素分析[J]. 疾病监测. doi: 10.3784/jbjc.202109130489
引用本文: 吕金芳, 李文霞, 黎美兰, 王永研, 郭桂莲. 海南省西部地区60岁及以上老年人群2型糖尿病的患病率及其影响因素分析[J]. 疾病监测. doi: 10.3784/jbjc.202109130489
Lyu Jinfang, Li Wenxia, Li Meilan, Wang Yongyan, Guo Guilian. Prevalence of type 2 diabetes and influencing factors in the elderly population aged 60 and above in western Hainan[J]. Disease Surveillance. doi: 10.3784/jbjc.202109130489
Citation: Lyu Jinfang, Li Wenxia, Li Meilan, Wang Yongyan, Guo Guilian. Prevalence of type 2 diabetes and influencing factors in the elderly population aged 60 and above in western Hainan[J]. Disease Surveillance. doi: 10.3784/jbjc.202109130489

海南省西部地区60岁及以上老年人群2型糖尿病的患病率及其影响因素分析

doi: 10.3784/jbjc.202109130489
基金项目: 海南省医药卫生科研基金(No. 17A200084)
详细信息
    作者简介:

    吕金芳,女,海南省儋州市人,本科,副主任护师,主要从事临床糖尿病防治工作

    通讯作者:

    吕金芳,Tel:0898–23322060, Email:13876615991@163.com

  • 中图分类号: R211; R587.1

Prevalence of type 2 diabetes and influencing factors in the elderly population aged 60 and above in western Hainan

Funds: This study was supported by the Hainan Medical and Health Research Fund Project (No. 17A200084)
More Information
  • 摘要:   目的   调查海南省西部地区60岁及以上老年人群2型糖尿病的患病现状及其影响因素,为该地区老年人群2型糖尿病的防治提供依据。  方法   采用多阶段整群随机抽样方法,抽取海南省西部地区4个市(县)60岁及以上老年人群进行调查。 收集调查对象的一般资料和生活方式,并进行体格检查及实验室检测。 应用单因素及多因素logistic回归分析影响老年2型糖尿病的相关影响因素。  结果   共纳入调查对象12 582人,2型糖尿病的患病率为30.52%(3 840/12 582),其中70~79岁的患病率最高,为32.24%(1 330/4 125)。 女性2型糖尿病的患病率明显高于男性(32.94% vs. 27.73%,χ2=40.037,P<0.001)。 多因素logistic回归分析显示,超重或肥胖、糖尿病家族史、高血压、长期焦虑或紧张、高尿酸及血脂异常与老年人群较高的2型糖尿病患病率有关(P<0.05)。  结论   海南省西部地区老年人群2型糖尿病的患病率较高,控制体质指数、血压、尿酸及血脂对老年2型糖尿病的防控具有重要意义。
  • 表  1  调查对象基本情况

    Table  1.   Basic information of respondents

     项目合计
    n=12 582)
    男性
    n=5 852)
    女性
    n=6 730)
    年龄组(岁)
    60~4938(39.25)2402(41.05)2536(37.68)
    70~4125(32.78)1769(30.23)2356(35.01)
    80~2573(20.45)1290(22.04)1283(19.06)
    ≥90946(7.52)391(6.68)555(8.25)
    文化程度
    初中及以下4395(34.93)1908(32.60)2487(36.95)
    中专/高中4538(36.07)2224(38.01)2314(34.39)
    大专/本科及以上3649(29.00)1720(29.39)1929(28.66)
    婚姻状况
    已婚9873(78.47)4481(76.58)5392(80.12)
    未婚564(4.48)404(6.90)160(2.38)
    丧偶2145(17.05)967(16.52)1178(17.50)
    家庭年收入(万元)
    < 12374(18.87)962(16.44)1412(20.98)
    1~4465(35.49)2028(34.65)2437(36.21)
    6~3962(31.48)1930(32.98)2032(30.19)
    ≥101781(14.16)932(15.93)849(12.62)
    体质指数(kg/m2
    正常6 746(53.62)3 033(51.83)3 713(55.17)
    偏瘦1 048(8.33)353(6.03 )695(10.33)
    超重3 683(29.27)1 930(32.98)1 753(26.05)
    肥胖1 105(8.78)536(9.16)569(8.45)
    注:括号外数据为人数(人),括号内数据为构成比(%)
    下载: 导出CSV

    表  2  不同年龄、性别2型糖尿病患病情况

    Table  2.   Prevalence of type 2 diabetes in different age and gender

    年龄组(岁)总计 男性 女性
    人数(人)患病数患病率(%) 人数(人)患病数患病率(%) 人数(人)患病数患病率(%)
    60~4 9381 52830.942 40270829.482 53682032.33
    70~4 1251 33032.241 76954530.802 35678533.32
    80~2 57373828.681 29028922.401 28344935.00
    ≥ 9094624425.793918120.7255516329.37
    合计125823 84030.525 8521 62327.736 7302 21732.94
    下载: 导出CSV

    表  3  2型糖尿病患病的单因素分析

    Table  3.   Univariate analysis of type 2 diabetes mellitus prevalence

    项目非糖尿病组
    n=8 742)
    糖尿病组
    n=3 840)
    χ2/ZP
    性别40.037< 0.001
    男性4 229(48.38)1 623(42.27)
    女性4513(51.62)2 217(57.73)
    民族0.1050.814
    汉族8 006(91.58)3 532(91.98)
    其他民族736(8.42)308(8.02)
    年龄组(岁)2.2540.133
    60~3 410(39.01)1 528(39.79)
    70~2 795(31.97)1 330(34.64)
    80~1 835(20.99)738(19.22)
    ≥90702(8.03)244(6.35)
    居住地1.6920.193
    城市4 516(51.66)2 032(52.92)
    农村4 226(48.34)1 808(47.08)
    体质指数(kg/m21 108.512<0.001
    正常5 602(64.08)1 144(29.79)
    偏瘦791(9.05)257(6.69)
    超重1 768(20.22)1 915(49.87)
    肥胖581(6.65)524(13.65)
    文化程度1.7120.191
    初中及以下3 044(34.82)1 351(35.18)
    中专/高中3 132(35.83)1 406(36.62)
    大专/本科
    及以上
    2 566(29.35)1 083(28.20)
    婚姻状况0.1170.732
    已婚6 826(78.08)3 047(79.35)
    未婚419(4.79)145(3.78)
    丧偶1497(17.12)648(16.88)
    家庭年收入
    (万元)
    3.1520.081
    <11 686(19.29)688(17.92)
    1~3 128(35.78)1 337(34.81)
    6~2 718(31.09)1 244(32.40)
    ≥101 210(13.84)571(14.87)
    糖尿病家族史1 483(16.96)985(25.65)127.691<0.001
    高血压2 851(32.61)2 306(60.05)830.515<0.001
    吸烟2 932(33.54)1 346(35.05)2.7210.099
    饮酒3 371(38.56)1 537(40.03)2.4070.121
    锻炼2 194(25.10)943(24.56)0.4160.519
    长期焦虑或紧张3 510(40.15)1 674(43.59)13.053<0.001
    睡眠不足903(10.33)424(11.04)1.4350.231
    食用油摄入过量2 745(31.40)1 241(32.32)1.0380.308
    高尿酸1 541(17.63)1 077(28.05)175.779<0.001
    血脂异常4 304(49.23)2 113(55.03)35.822<0.001
    注:年龄、体质指数的比较采用秩和检验;括号外数据为病例数(例),括号内数据为构成比(%)
    下载: 导出CSV

    表  4  2型糖尿病患病的多因素logistic回归分析

    Table  4.   Multivariate logistic regression analysis of type 2 diabetes mellitus prevalence

     变量B标准误Wald χ2OR
    (95% CI
    P
    超重或肥胖1.5830.40615.2024.865
    (3.517~10.142)
    < 0.001
    糖尿病家族史1.0820.28414.5132.951
    (1.873~6.912)
    < 0.001
    高血压0.9110.17527.1012.487
    (1.435~5.368)
    < 0.001
    长期焦虑或紧张0.7180.2736.9172.052
    (1.396~4.995)
    0.013
    高尿酸1.4600.36916.1184.306
    (3.142~9.783)
    < 0.001
    血脂异常1.1740.35211.1233.237
    (2.105~7.428)
    < 0.001
    注:超重或肥胖(正常=0/偏瘦=1/超重或肥胖=2),糖尿病家族史(是=1/否=0),高血压(是=1/否=0),长期焦虑或紧张(是=1/否=0),高尿酸(是=1/否=0),血脂异常(是=1/否=0)
    下载: 导出CSV
  • [1] Lovic D, Piperidou A, Zografou I, et al. The growing epidemic of diabetes mellitus[J]. Curr Vasc Pharmacol, 2020, 18(2): 104–109. DOI:  10.2174/1570161117666190405165911.
    [2] Liu JL, Ren ZH, Qiang H, et al. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention[J]. BMC Public Health, 2020, 20(1): 1415. DOI: 10.1186/s12889−020−09502−x.
    [3] Lu JY, Wang CF, Shen Y, et al. Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study[J]. Diabetes Care, 2021, 44(2): 549–555. DOI: 10.2337/dc20−1862.
    [4] Liu C, Li XJ, Lin MH, et al. A cross-sectional study on diabetes epidemiology among people aged 40 years and above in Shenyang, China[J]. Sci Rep, 2020, 10(1): 17742. DOI: 10.1038/s41598−020−74889−x.
    [5] Carstensen B, Rønn PF, Jørgensen ME. Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996–2016[J]. BMJ Open Diabetes Res Care, 2020, 8(1): e001071. DOI: 10.1136/bmjdrc−2019−001071.
    [6] Altobelli E, Angeletti PM, Profeta VF, et al. Lifestyle risk factors for type 2 diabetes mellitus and national diabetes care systems in European countries[J]. Nutrients, 2020, 12(9): 2806. DOI:  10.3390/nu12092806.
    [7] Xie LD, Zhao X, Zhang B, et al. Epidemiology and risk factors for diabetes in the suburbs of Beijing: a retrospective cohort study[J]. BMJ Open, 2021, 11(3): e041526. DOI: 10.1136/bmjopen−2020−041526.
    [8] 国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会. 中国老年糖尿病诊疗指南(2021年版)[J]. 中华糖尿病杂志,2021,13(1):14–46. DOI:10.3760/cma.j.cn115791−20201209−00707.

    National Geriatrics Center, Geriatrics Branch of Chinese Medical Association, Diabetes Specialized Committee of China Geriatric Health Association. Guideline for the management of diabetes mellitus in the elderly in China (2021 edition)[J]. Chin J Diabetes Mellitus, 2021, 13(1): 14–46. DOI: 10.3760/cma.j.cn115791−20201209−00707.
    [9] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志,2019,24(1):24–56. DOI:10.3969/j.issn.1007−5410.2019.01.002.

    China Hypertension Prevention and Treatment Guidelines Revision Committee Guidelines, CHL, CSC, et al. 2018 Chinese guidelines for the management of hypertension[J]. Chin J Cardiovasc Med, 2019, 24(1): 24–56. DOI: 10.3969/j.issn.1007−5410.2019.01.002.
    [10] 中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志,2020,36(1):1–13. DOI:10.3760/cma.j.issn.1000−6699.2020.01.001.

    Chinese Society of Endocrinology. Guideline for the diagnosis and management of hyperuricemia and gout in China (2019)[J]. Chin J Endocrinol Metab, 2020, 36(1): 1–13. DOI: 10.3760/cma.j.issn.1000−6699.2020.01.001.
    [11] 中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华心血管病杂志,2016,44(10):833–853. DOI:10.3760/cma.j.issn.0253−3758.2016.10.005.

    Joint Committee Issued Chinese Guideline for the Management Dyslipidemia in Adults. 2016 Chinese guideline for the management of dyslipidemia in adults[J]. Chin J Cardiol, 2016, 44(10): 833–853. DOI: 10.3760/cma.j.issn.0253−3758.2016.10.005.
    [12] Kalan Farmanfarma KH, Ansari-Moghaddam A, Zareban I, et al. Prevalence of type 2 diabetes in Middle-East: Systematic review & meta-analysis[J]. Prim Care Diabetes, 2020, 14(4): 297–304. DOI:  10.1016/j.pcd.2020.01.003.
    [13] Liang B, Tang WW, Zhang WQ, et al. Prevalence and associated factors of diabetes mellitus in a very elderly Chinese population: a cross-sectional study[J]. Biomed Environ Sci, 2020, 33(5): 315–322. DOI:  10.3967/bes2020.043.
    [14] 潘磊磊, 卢春明, 吴明, 等. 辽宁省35~75岁居民糖尿病患病率及影响因素[J]. 中华疾病控制杂志,2020,24(6):670–675. DOI: 10.16462/j.cnki.zhjbkz.2020.06.010.

    Pan LL, Lu CM, Wu M, et al. Analysis on the diabetes prevalence and its influencing factors in population aged 35–75 years in Liaoning province[J]. Chin J Dis Control Prev, 2020, 24(6): 670–675. DOI:  10.16462/j.cnki.zhjbkz.2020.06.010.
    [15] Carstensen B, Rønn PF, Jørgensen ME. Components of diabetes prevalence in Denmark 1996-2016 and future trends until 2030[J]. BMJ Open Diabetes Res Care, 2020, 8(1): e001064. DOI: 10.1136/bmjdrc−2019−001064.
    [16] 罗文婷, 戴龙. 厦门市老年人高血压及糖尿病患病情况分析[J]. 中国公共卫生,2019,35(8):1006–1009. DOI: 10.11847/zgggws1120189.

    Luo WT, Dai L. Prevalence of hypertension and diabetes in elderly people in Xiamen city[J]. Chin J Public Health, 2019, 35(8): 1006–1009. DOI:  10.11847/zgggws1120189.
    [17] 田园梦, 井丽, 张博强, 等. 2018年辽宁省农村40岁及以上居民糖尿病患病率及其相关危险因素分析[J]. 现代预防医学,2020,47(7):1300–1304.

    Tian YM, Jing L, Zhang BQ, et al. Prevalence and related risk factors of diabetes in residents aged 40 and over in rural areas, Liaoning, 2018[J]. Mod Prev Med, 2020, 47(7): 1300–1304.
    [18] 施明明, 张晓, 李娜, 等. 杭州市上城区成人糖尿病流行现况及相关因素分析[J]. 中国慢性病预防与控制,2019,27(4):276–280. DOI:10.16386/j.cjpccd.issn.1004−6194.2019.04.009.

    Shi MM, Zhang X, Li N, et al. Prevalence and related factors of adult diabetes mellitus in Shangcheng district, Hangzhou, China[J]. Chin J Prev Control Chronic Dis, 2019, 27(4): 276–280. DOI: 10.16386/j.cjpccd.issn.1004−6194.2019.04.009.
    [19] 周棉勇, 管慧, 张灵慧, 等. 贵州省东南部地区≥15岁居民心脑血管疾病患病情况及其影响因素分析[J]. 中国公共卫生,2020,36(8):1121–1127. DOI: 10.11847/zgggws1124069.

    Zhou MY, Guan H, Zhang LH, et al. Prevalence and influence factors of cardiovascular disease among residents aged 15 years and above in southeast Guizhou province[J]. Chin J Public Health, 2020, 36(8): 1121–1127. DOI:  10.11847/zgggws1124069.
    [20] Sun YY, Ni WQ, Yuan XL, et al. Prevalence, treatment, control of type 2 diabetes and the risk factors among elderly people in Shenzhen: results from the urban Chinese population[J]. BMC Public Health, 2020, 20(1): 998. DOI: 10.1186/s12889−020−09045−1.
    [21] 郭伶俐, 叶霖, 袁姣. 45岁及以上人群糖尿病的流行现状及影响因素研究[J]. 现代预防医学,2019,46(16):2890–2894.

    Guo LL, Ye L, Yuan J. Prevalence and influencing factors of diabetes for the 45 years and older population in China[J]. Mod Prev Med, 2019, 46(16): 2890–2894.
    [22] 李贤, 王惠群, 吴延莉, 等. 贵州省2型糖尿病和糖尿病前期流行现状及影响因素分析[J]. 中国慢性病预防与控制,2021,29(5):373–376. DOI:10.16386/j.cjpccd.issn.1004−6194.2021.05.012.

    Li X, Wang HQ, Wu YL, et al. Prevalence and influencing factors of type 2 diabetes mellitus and pre-diabetes in Guizhou province[J]. Chin J Prev Control Chronic Dis, 2021, 29(5): 373–376. DOI: 10.16386/j.cjpccd.issn.1004−6194.2021.05.012.
  • 加载中
计量
  • 文章访问数:  83
  • HTML全文浏览量:  49
  • PDF下载量:  17
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-09-13
  • 网络出版日期:  2022-04-19

目录

    /

    返回文章
    返回

    在线交流

    防诈骗公告

    近期有不法分子以本刊编辑身份添加作者微信,请务必提高警惕!本刊关于稿件的一切事项通知均采用编辑部唯一邮箱(jbjc@icdc.cn)和座机(010-58900732)联系作者,且在录用稿件后仅收取版面费,无其他任何名目费用(如审稿费和加急费等),非编辑部邮箱发送的本刊收费用通知等均为诈骗,不要随意汇入款项!如有可疑及时致电编辑部核实确认!